First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis

Articolo

Data di Pubblicazione:

2024

Citazione:

First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis / Ghia, Paolo; Owen, Carolyn; Allan, John N; Barrientos, Jacqueline C; Barr, Paul M; Shi, Chunxue; Szoke, Anita; Abbazio, Christopher; Krigsfeld, Gabriel S; Burger, Jan A. - In: HEMASPHERE. - ISSN 2572-9241. - 8:5(2024). [10.1002/hem3.74]

Tipologia CRIS:

1.1.2. Articolo in Rivista - Letter, Note

Elenco autori:

Ghia, Paolo; Owen, Carolyn; Allan, John N; Barrientos, Jacqueline C; Barr, Paul M; Shi, Chunxue; Szoke, Anita; Abbazio, Christopher; Krigsfeld, Gabriel S; Burger, Jan A

Autori di Ateneo:

GHIA PAOLO PROSPERO

Link alla scheda completa:

https://iris.unisr.it/handle/20.500.11768/168998

Link al Full Text:

https://iris.unisr.it//retrieve/handle/20.500.11768/168998/314819/HemaSphere%20-%202024%20-%20Ghia%20-%20First%BFline%20ibrutinib%20treatment%20in%20patients%20with%20chronic%20lymphocytic%20leukemia%20is%20associated%20with.pdf

Pubblicato in:

HEMASPHERE

Journal